10 at 10: These ASX stocks have put on a strong performance this morning
News
News
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
Code | Company | Price | % | Volume |
---|---|---|---|---|
CLZ | Classic Min Ltd | 0.0015 | 50 | 11155000 |
WC8 | Wildcat Resources | 0.044 | 33 | 3418631 |
CYQ | Cycliq Group Ltd | 0.004 | 33 | 150000 |
CPH | Creso Pharma Ltd | 0.078 | 24 | 27171856 |
A1M | Aic Mines Ltd | 0.44 | 21 | 5000 |
CGB | Cann Global Limited | 0.006 | 20 | 982800 |
RNX | Renegade Exploration | 0.007 | 16 | 1500000 |
IDA | Indiana Resources | 0.069 | 14 | 92700 |
BLU | Blue Energy Limited | 0.064 | 14 | 6144903 |
M8S | M8 Sustainable | 0.065 | 13 | 354925 |
Perth-based landfill operator M8 Sustainable (ASX:M8S) rose after an operational update.
Queensland gas play Blue Energy (ASX:BLU) also rose after signing a gas supply agreement with Energy Australia.
Cannabis stock Creso Pharma (ASX:CPH) climbed after commenting on overnight developments at the United Nations. The UN opted to reclassify cannabis out of the most dangerous category of drugs.
Code | Company | Price | % | Volume |
---|---|---|---|---|
APG | Austpac Resources NL | 0.001 | -50 | 40113 |
XPE | Xped Limited | 0.001 | -50 | 1154500 |
ECT | Env Clean Tech Ltd. | 0.001 | -33 | 500000 |
UUV | UUV Aquabotix Ltd | 0.001 | -33 | 500000 |
TPD | Talon Petroleum Ltd | 0.003 | -25 | 183333 |
MYG | Mayfield Group Ltd | 0.51 | -22 | 68249 |
VPR | Volt Power Group | 0.002 | -20 | 484999 |
XTC | Xantippe Res Ltd | 0.002 | -20 | 666666 |
YPB | YPB Group Ltd | 0.002 | -20 | 250000 |
MEB | Medibio Limited | 0.01 | -17 | 30056396 |
Medibio (ASX: MEB) dropped after getting rejected by the FDA.